Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: an embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma

  • 1, 2,
  • 1Email author,
  • 1,
  • 2,
  • 2 and
  • 1
Journal of Experimental & Clinical Cancer Research201433:22

https://doi.org/10.1186/1756-9966-33-22

  • Received: 18 February 2014
  • Accepted: 18 February 2014
  • Published:

The original article was published in Journal of Experimental & Clinical Cancer Research 2010 29:135

Correction

In Figure two of our article [1], panel A inadvertently contains a duplication of panel B. This error was made during the arrangement of the figure panels. The corrected, revised Figure two (Figure 1 here) is shown below. The error does not affect any conclusions drawn in the article. We regret any inconvenience this has caused.
Figure 1
Figure 1

Expression kinetics of Ecat1, Dppa5, and GDF3 during tumorigenesis. B16-F1 and B16-F10 cells were injected subcutaneously into C57BL/6 mice. Tumors were excised on the indicated day. Total RNA was extracted from the tumor and RT-PCR (A-D) or RT-qPCR (E, F) was performed to detect Ecat1, Dppa5, and GDF3. (A, B) RT-PCR analyses revealed that mRNA of Eca1 and Dppa5 decreased during tumorigenesis. (C, E) In B16-F1 cells, GDF3 peaked at day 7 after tumor injection and then gradually decreased. (D, F). In contrast, GDF3 expression in B16-F10 cells increased 7 days after tumor injection and maintained a high level until 14 days after injection.

Notes

Declarations

Authors’ Affiliations

(1)
Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-8638, Japan
(2)
Department of Gastroenterology, Graduate School of Medicine, Hokkaido University, Kita-15, Nishi-7, Kita-ku, Sapporo 060-8638, Japan

References

  1. Ehira N, Oshiumi H, Matsumoto M, Kondo T, Asaka M, Seya T: An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma. J Exp Clin Cancer Res. 2010, 29: 135-10.1186/1756-9966-29-135.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

Advertisement